EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Preventing First and Further Decompensation in Advanced Chronic Liver Disease

Leonardo Corrêa Süffert iD, Bernardo de Faria Moraes iD, Guilherme Grossi Lopes Cançado iD

Liver International · 2026-04 · 46 (4)

DOI: 10.1111/liv.70568 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Liver International, online erschienen am 03.03.2026. Verfasst von Leonardo Corrêa Süffert und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Pontifícia Universidade Católica Do Rio Grande Do Sul, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Hypertension, Portal, Liver Diseases. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced chronic liver disease (ACLD) remains a major cause of global morbidity and mortality. Preventing hepatic decompensation—both the first event and subsequent recurrences—has become a central therapeutic goal to prolong survival. The transition from the compensated phase (cACLD) to the decompensated phase (dACLD) is driven by clinically significant portal hypertension (CSPH) and continuous exposure to etiologic factors, and is often precipitated by systemic triggers such as infections, portal vein thrombosis, and hepatocellular carcinoma. Thus, effective prevention requires a multidisciplinary strategy combining etiologic control with hemodynamic modulation, supported by vaccination, optimized nutrition and physical activity, judicious endoscopic therapy, and a critical reassessment of antibiotic prophylaxis in the era of antimicrobial resistance. Among non‐selective beta‐blockers (NSBBs), carvedilol—through combined β1/β2 and α1 blockade—achieves a greater reduction in hepatic venous pressure gradient (HVPG) than propranolol and demonstrates superiority in preventing first decompensation. In dACLD, although the effect of NSBBs is attenuated, carvedilol still emerges as the preferred option, given that propranolol shows significantly lower efficacy at this stage. Endoscopic variceal ligation (EVL) remains an alternative for NSBB‐intolerant patients in cACLD and is essential for secondary prophylaxis. Moreover, in dACLD, the combination of EVL with carvedilol is increasingly being explored in Child‐Pugh B/C patients. We provide an overview of pathophysiological mechanisms, risk stratification using non‐invasive tests, and pragmatic prevention strategies across the different stages of disease, emphasizing recompensation, the NSBB “therapeutic window,” and the need to revisit routine antibiotic prophylaxis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PortalLiver DiseasesHumansAdrenergic beta-AntagonistsCarvedilolEsophageal and Gastric VaricesChronic DiseaseLigationCarbazoles

Stichwörter der Autor:innen

TIPSasciteshaemorrhagehepatic encephalopathyliver cirrhosisrecompensation

Substanzen

Adrenergic beta-AntagonistsCarvedilolCarbazoles

Autor:innen und Institutionen

  • School of Medicine, Pontifícia Universidade Católica Do Rio Grande Do Sul, Porto Alegre, Brazil.
  • Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Department of Gastroenterology and Hepatology, Hospital da Polícia Militar de Minas Gerais, Belo Horizonte, Brazil.

ORCID-Profile: Leonardo Corrêa Süffert, Bernardo de Faria Moraes, Guilherme Grossi Lopes Cançado

Zitieren

APA

Süffert, L. C., de Faria Moraes, B., & Cançado, G. G. L. (2026). Preventing First and Further Decompensation in Advanced Chronic Liver Disease. Liver International, 46(4). https://doi.org/10.1111/liv.70568

Vancouver

Süffert LC, de Faria Moraes B, Cançado GGL. Preventing First and Further Decompensation in Advanced Chronic Liver Disease. Liver International. 2026;46(4). doi:10.1111/liv.70568

BibTeX
@article{Sffert2026,
  author = {Süffert, Leonardo Corrêa and de Faria Moraes, Bernardo and Cançado, Guilherme Grossi Lopes},
  title = {Preventing First and Further Decompensation in Advanced Chronic Liver Disease},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {4},
  doi = {10.1111/liv.70568}
}
Kostenlos starten →